Li et al. reported that SIRT2 mRNA and protein expression was downregulated in eight primary glioma samples (grade II n = 2, grade III n = 5, and grade IV n = 1) versus four normal brain tissue samples tested. This evidence concerns the gene SIRT2 and central nervous system cancer.